American Bio Medica Appoints Daniel W. Kollin To Its Board Of Directors.Business Editors KINDERHOOK, N.Y.--(BUSINESS WIRE)--Feb. 12, 2003 American Bio Medica medica (māˑ·dē·k Corporation (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :ABMC ABMC American Battle Monuments Commission ABMC Alexian Brothers Medical Center (Illinois) ABMC Aviation Battle Management Concept ABMC Arrowbear Music Camp (California) ) today announced that at a regular meeting held on February 5, 2003, the ABMC Board of Directors appointed Daniel W. Kollin to serve as a member of its Board of Directors. Kollin's appointment brings the total number of ABMC board members to seven. Mr. Kollin, 61, is a principal of BioMed Capital Group, Ltd., a firm that provides strategic and business advisory services advisory services advisory services provided to the public, in their capacity as owners and managers of animals, are an important part of veterinary science. They may be provided by government bureaux, by commercial companies who deal in pharmaceuticals or animals or animal . Kollin has over twenty years TWENTY YEARS. The lapse of twenty years raises a presumption of certain facts, and after such a time, the party against whom the presumption has been raised, will be required to prove a negative to establish his rights. 2. experience in investment banking, venture capital and corporate management, specializing in pharmaceutical, biotechnology and healthcare companies in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. and Europe. Kollin previously served as a Vice President of Prudential-Bache Capital Funding and Director of Corporate Finance and partner of Whale Securities Corp. Before his involvement in the financial services industry, Kollin held marketing, planning and development executive positions with Becton-Dickinson and Co. and Sandoz, Inc. Mr. Kollin currently serves on the Board of Directors of GenSci Regeneration Sciences Inc. (TORONTO:GNS GNS GEOnet Names Server (NIMA) GNS Global Network Services (INMARSAT) GNS Guinea Franc GNS Get Nearest Server (component of IPX and SAP) GNS Global Navigation System .TO). He received his MBA MBA abbr. Master of Business Administration Noun 1. MBA - a master's degree in business Master in Business, Master in Business Administration from The Wharton School of the University of Pennsylvania The Wharton School is the business school of University of Pennsylvania in Philadelphia, Pennsylvania. It was established in 1881 through a donation of Joseph Wharton, making it the world’s oldest business school. . Gerald A. Moore, Chairman and Chief Executive Officer of ABMC commented, "We are proud to have a professional of Dan's caliber join our Board of Directors. He brings extensive strategic financial and management expertise in the fields of healthcare and biotechnology. We are confident he will be an important asset to our Board of Directors." Moore added, "The addition of Dan further enhances the independent structure of our board, bringing the number of independent directors to four." About American Bio Medica Corporation American Bio Medica Corporation is a biotechnology company that develops, manufactures and markets inexpensive, accurate, immunoassay Immunoassay An assay that quantifies antigen or antibody by immunochemical means. The antigen can be a relatively simple substance such as a drug, or a complex one such as a protein or a virus. diagnostic test kits, including some of the world's most effective on-site drugs of abuse tests. The company and its worldwide distribution network target the workplace, government, corrections, clinical and educational markets. ABMC's Rapid Drug Screen(R), Rapid One(R), and Rapid Tec(TM) test for the presence or absence of drugs of abuse in urine, while OralStat6(R) tests for the presence or absence of drugs of abuse in saliva. ABMC was recently named among the 2002 Deloitte & Touche Technology Fast 500, a listing of the fastest-growing technology companies in North America. This release may contain forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results to differ, and such differences could be material. Such risks and uncertainties include, but are not limited to, the following: continued acceptance of the Company's products, increased levels of competition in our industry, the acceptance of new products, inherent risks associated with product development and intellectual property rights, the Company's dependence on key personnel, third party sales and suppliers. There can be no assurance that the Company will be successful in addressing such risks and uncertainties. Investors are strongly encouraged to review the section entitled "Risk Factors" in the Company's annual report on Form 10-KSB for the transition period ended December 31, 2001, and quarterly reports on Form 10-QSB on file with the Securities and Exchange Commission for a discussion of risks and uncertainties that could affect operating results and the market price of the Company's common shares. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion